Clinical Trial

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage cancer cells. Combining chemotherapy with radiation therapy may kill more cancer cells. It is not yet known which combination chemotherapy regimen is most effective in treating Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to compare the effectiveness of different regimens of combination chemotherapy with or without radiation therapy in treating patients who have Hodgkin's lymphoma.
Protocol Amendment History 20 amendments
This ClinicalTrials.gov record has been amended 20 times since 2005-06-23; most recent amendment 2025-08-04.
Trial Details
NCT Number NCT00005584
Lead Sponsor European Organisation for Research and Treatment of Cancer - EORTC
Collaborators: Lymphoma Study Association, UNICANCER
Conditions Lymphoma
Enrollment 1,649 participants
Start Date 1998-10
Primary Completion 2004-05 (estimated)
Updated on ClinicalTrials.gov 2025-08-05